Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 5, pp. 1-9
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
ACE2-Independent Alternative Receptors for SARS-CoV-2
Suhyeon Lim, Monica Zhang, Theresa L. Chang
Viruses (2022) Vol. 14, Iss. 11, pp. 2535-2535
Open Access | Times Cited: 73
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage
Tiago J. Costa, Simone R. Potje, Thais Fernanda de Campos Fraga‐Silva, et al.
Vascular Pharmacology (2021) Vol. 142, pp. 106946-106946
Open Access | Times Cited: 98
Choosing a cellular model to study SARS-CoV-2
Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 43
Experimental Models of COVID-19
Luis A. Caldera-Crespo, Michael J. Paidas, Sabita Roy, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 41
The role of dendritic cells in COVID-19 infection
Xuying Wang, Fei Guan, H. I. Miller, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Exploring dual applications of gliptins: A potential host-targeted strategy for diabetes and COVID-19 co-morbidity
Aditi Nag, Y.P. Baid, Mudit Tyagi
Medical Hypotheses (2025), pp. 111602-111602
Closed Access | Times Cited: 1
Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
Zena Wehbe, Safaa Hisham Hammoud, Hadi M. Yassine, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
CAR T cells: engineered immune cells to treat brain cancers and beyond
Zoufang Huang, Saikat Dewanjee, Pratik Chakraborty, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
Matteo Pavan, Davide Bassani, Mattia Sturlese, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1704-1714
Open Access | Times Cited: 23
Physicochemical Nature of SARS-CoV-2 Spike Protein Binding to Human Vimentin
Piotr Deptuła, Krzysztof Fiedoruk, Monika Wasilewska, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 28, pp. 34172-34180
Open Access | Times Cited: 14
Insulin and Metformin Administration: Unravelling the Multifaceted Association with Mortality across Various Clinical Settings Considering Type 2 Diabetes Mellitus and COVID-19
Łukasz Lewandowski, Agnieszka Bronowicka-Szydełko, Maciej Rabczyński, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 605-605
Open Access | Times Cited: 4
Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternative Route to Brain Infection in COVID-19
Katarzyna Bilińska, Christopher S. von Bartheld, Rafał Butowt
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 26
Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms
Chuan Xu, Annie Wang, Ke Geng, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 953-953
Open Access | Times Cited: 25
Cell therapy strategies for COVID-19: Current approaches and potential applications
Mark M. Zaki, Emal Lesha, Khaled Saïd, et al.
Science Advances (2021) Vol. 7, Iss. 33
Open Access | Times Cited: 24
Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
Valery A. Petrenko, James W. Gillespie, Laura M. De Plano, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 384-384
Open Access | Times Cited: 19
Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?
Mohamed Hessien, Thoria Donia, Ashraf A. Tabll, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1040-1040
Open Access | Times Cited: 10
Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation
Hsu-Yu Chen, Chun Huang, Lü Tian, et al.
Journal of Virology (2021) Vol. 95, Iss. 22
Open Access | Times Cited: 23
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 9
Toll like receptor 4 mediates the inhibitory effect of SARS-CoV-2 spike protein on proximal tubule albumin endocytosis
Rodrigo P. Silva‐Aguiar, Douglas E. Teixeira, Diogo B. Peruchetti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167155-167155
Closed Access | Times Cited: 3
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, et al.
Advances in Biological Regulation (2021) Vol. 81, pp. 100820-100820
Open Access | Times Cited: 19
SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19
Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 19
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
Raluca Dumache, Alexandra Enache, Ioana Macașoi, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 516-516
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top